AS70 - Moligand™ , Antagonist of A 1 receptor;Antagonist of A 2B receptor, CAS No.A607761, Antagonist of A 1 receptor;Antagonist of A 2B receptor

CAS: A607761 Cat. No.: A607761
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
Storage
Room temperature
★
Size
USA
Germany (EU)*
Price
Qty
5mg
A607761-5mg
Made to order · 8–12 wks

$1,142.90

$1,334.90
Save $192.00 (14.38%)
25mg
A607761-25mg
Made to order · 8–12 wks

$1,714.90

$2,000.90
Save $286.00 (14.29%)
Enter a quantity for the sizes you want to add.

Specifications

Specifications & Purity
Moligand™
Storage
Room temperature
Grade
Moligand™
Action Type
ANTAGONIST
Mechanism of action
Antagonist of A 1 receptor;Antagonist of A 2B receptor
Names and Identifiers
SMILES
CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)N1CCN(CC1)c1ccccc1
IUPAC Name
8-{1-methyl-3-[2-oxo-2-(4-phenylpiperazin-1-yl)ethoxy]-1H-pyrazol-5-yl}-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purine-2,6-dione
InChIKey
BVHLYIIHYJFKSI-UHFFFAOYSA-N
InChI
1S/C27H34N8O4/c1-4-11-34-25-23(26(37)35(12-5-2)27(34)38)28-24(29-25)20-17-21(30-31(20)3)39-18-22(36)33-15-13-32(14-16-33)19-9-7-6-8-10-19/h6-10,17H,4-5,11-16,18H2,1-3H3,(H,28,29)
Isomeric SMILES
CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC(=NN3C)OCC(=O)N4CCN(CC4)C5=CC=CC=C5
Reaxys
9677185
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9677185&ln=

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClassDiazinanes
SubclassPiperazines
Intermediate Tree Nodes Not available
Direct ParentPhenylpiperazines
Alternative Parents N-arylpiperazines  Xanthines  6-oxopurines  Alkaloids and derivatives  Aniline and substituted anilines  Dialkylarylamines  Alkyl aryl ethers  Pyrimidones  Vinylogous amides  Tertiary carboxylic acid amides  Pyrazoles  Heteroaromatic compounds  Imidazoles  Amino acids and derivatives  Ureas  Lactams  Azacyclic compounds  Carbonyl compounds  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Phenylpiperazine - N-arylpiperazine - Xanthine - 6-oxopurine - Purinone - Imidazopyrimidine - Purine - Alkaloid or derivatives - Aniline or substituted anilines - Dialkylarylamine - Tertiary aliphatic/aromatic amine - Alkyl aryl ether - Pyrimidone - Monocyclic benzene moiety - Benzenoid - Pyrimidine - Azole - Imidazole - Heteroaromatic compound - Vinylogous amide - Pyrazole - Tertiary carboxylic acid amide - Tertiary amine - Urea - Amino acid or derivatives - Carboxamide group - Lactam - Ether - Carboxylic acid derivative - Azacycle - Organic oxygen compound - Carbonyl group - Organic oxide - Hydrocarbon derivative - Organic nitrogen compound - Organonitrogen compound - Organooxygen compound - Amine - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as phenylpiperazines. These are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
ADORA2B Tclin Adenosine receptor A2b (7 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA1 Tclin Adenosine receptor A1 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2B Tclin Adenosine A2b receptor (7672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2B Tclin Adenosine receptors; A2b & A3 (335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Associated Targets(non-human)
Adora2b Adenosine A2 receptor (1828 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mechanisms of Action
Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Safety and Hazards(GHS)
Reaxys
9677185
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9677185&ln=
Solution Calculators
Reviews

Customer Reviews

Application Protocols

No tested applications or protocols are provided for AS70 in the Product Data, and none are implied. Only item-specific, vendor-validated protocols may be listed here.

Item-specific recommended dilutions, positive controls, or assay conditions: Not specified for this item; refer to CoA/Spec Sheet.

Note: For general discovery workflows, develop fit-for-purpose protocols internally and validate with appropriate controls; however, such general methods are not item-specific and are therefore not listed here.

Biological Roles

Item-specific biological function, target class, or mode of action for AS70 are not provided and should be considered unknown until determined experimentally.

General considerations for small-molecule library members (not item-specific):

  • Potential roles: May act as an enzyme inhibitor/activator, receptor ligand, ion channel modulator, or pathway probe depending on structure and context.
  • Annotation pathway: Begin with primary screening hits, validate with dose–response confirmation, then use orthogonal biophysical methods (SPR, ITC, CETSA) to substantiate direct binding. Follow with chemoproteomics or genetic perturbation to deconvolute targets.
  • Off-target risks: Aggregation, redox cycling, and assay interference (fluorescence quenching/inner-filter effects) can mimic biological activity; employ counter-screens and control conditions.
  • ADME-relevant properties (general): Permeability, efflux susceptibility, and metabolic stability are structure-dependent and must be established empirically.

Item-specific claims about biological pathways, targets, or effects: Not specified for this item; refer to CoA/Spec Sheet. All uses are for research only.

Buffer Applications

This item is a small-molecule library member and is not itself a buffering agent. No item-specific buffer system information is provided.

General practical guidance (not item-specific):

  • Assay buffers: Choose buffers that maintain activity of the biological system (e.g., HEPES, PBS, Tris) and tolerate the minimal DMSO required to solubilize the compound (often 0.1–1% v/v).
  • Additives: Low levels of non-ionic detergents (e.g., 0.01–0.05% Tween-20) can mitigate aggregation artifacts during screening.
  • pH effects: If the compound is ionizable (unknown here), assay pH will modulate solubility and permeability; run small pH panels (e.g., pH 6.5–8.0 for enzyme/cell assays) to check robustness.

Item-specific buffer recipes, pH ranges, or compatibility: Not specified for this item; refer to CoA/Spec Sheet.

Green Alternatives

Without item-specific solvent or process requirements, “green” considerations focus on how AS70 might be handled in discovery workflows. The points below are general/literature guidance and not specifications for this SKU.

Greener solvent choices for preparation/analysis (general):

  • Prefer ethanol or 2-propanol over acetonitrile/methanol where assay/analytics allow (reduced toxicity, better safety profile).
  • For synthetic follow-up (if any), consider 2-MeTHF or CPME instead of THF/Et2O, and ethyl acetate instead of DCM (general green chemistry literature).

Workflow-level improvements (general):

  • Miniaturize assays (low-volume plates, 384–1536 wells) to reduce solvent and reagent usage.
  • Use aqueous buffers with ≤0.5% DMSO where feasible to reduce organic content, confirming compound solubility and assay integrity.
  • Plate management: Employ low-dead-volume dispensing and sealed storage to minimize evaporative loss and waste.

Trade-offs (general):

  • Greener solvents may decrease solubility or alter assay kinetics; verify performance with small pilot studies.
  • Replacing ACN in LC with MeOH or EtOH can change selectivity and pressure; method redevelopment may be required.

Item-specific environmental metrics (e.g., E-factor, solvent selection guide rating, biodegradability): Not specified for this item; refer to CoA/Spec Sheet.

Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation data are provided for this item. This product is supplied strictly for research use only; not for human or veterinary use.

General context for discovery compounds (not item-specific):

  • Early research utility: As a screening tool compound or hit/lead candidate in preclinical discovery, subject to extensive profiling (selectivity, ADME, safety) before any consideration for development.
  • Formulation screening (research stage): DMSO stocks for in vitro; for in vivo research (if permitted institutionally), co-solvent systems (e.g., PEG400/saline, Captisol) are common, but such use requires internal review and is outside the scope of this product page.
  • Regulatory: No compendial monograph or GMP status implied by Moligand grade.

Item-specific excipient applicability, dosage form compatibility, or GMP details: Not specified for this item; refer to CoA/Spec Sheet.

Physical Properties

Only item-specific properties listed below are definitive; all others are general/literature guidance.

Item-specific (from Product Data):

  • Physical state/appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.

General/literature guidance for small-molecule screening compounds (not specific to AS70):

  • Melting/boiling point: Typically compound-dependent; many drug-like solids melt in the 80–250 C range; oils have no sharp MP (literature trends).
  • LogP/cLogP: Often 1–4 for drug-like chemotypes; determine experimentally by shake-flask or calculate cLogP (literature).
  • pKa: If ionizable groups are present, pKa commonly falls within 3–11; measure by potentiometric titration or UV-spectrophotometric methods (literature).
  • Solubility: DMSO is the preferred primary solvent for screening stocks; aqueous solubility varies widely and depends on ionization state and counterion (literature/best practice).
  • Density/refractive index: Material-specific; measure if needed for formulation or analytical calibration.

Recommendations (general best practice):

  • Establish a solubility profile in DMSO and in assay buffer with 0–2% DMSO cosolvent; assess turbidity by nephelometry or plate-reader light scatter.
  • If polymorphism is suspected, use DSC/XRPD to characterize solid form prior to quantitative work (literature practice).
Quality & Grades

Item-specific:

  • Grade/Purity: Moligand™ (as provided). No numeric purity or stabilizer information is specified for this item; refer to CoA/Spec Sheet for assay and impurity limits.

What Moligand-grade typically implies (general description, not a specification for this SKU):

  • Intended for ligand discovery, screening, chemogenomics, and SAR initiation.
  • Emphasis on unambiguous identity and practical purity for biochemical/cellular assays, commonly supported by LC–MS and/or NMR identity checks (vendor CoA).
  • Packaging suited for parallel screening workflows (aliquot-friendly vials/plates), with attention to minimizing adventitious moisture and carryover.

How to interpret grade statements (general guidance):

  • Absence of numeric purity does not preclude suitability for screening; review chromatographic purity, identity spectra, and residual solvent/moisture on the CoA.
  • If UV cutoffs, metal limits, or stabilizers are critical to your application (e.g., photochemical assays, metal-catalyzed reactions), request the detailed Spec Sheet.

Recommended incoming QC (best practice):

  • Verify identity by HRMS and 1H NMR; compare retention time and purity profile by HPLC/UPLC against the CoA.
  • If plate-based screening is planned, test a small aliquot for precipitation in assay buffer at working DMSO percentages (e.g., 0.1–1%).

Stabilizers/antioxidants: Not specified for this item; refer to CoA/Spec Sheet.

Reaction & Applications

This product is categorized under small molecules/compound libraries and Moligand-grade materials. Without a disclosed structure or functional groups, synthetic reaction guidance cannot be item-specific. The following focuses on discovery applications that are typical for such compounds (general guidance).

Discovery and screening uses (general):

  • Biochemical target screening: Enzyme or receptor assays (fluorescence, absorbance, luminescence) to detect activity shifts upon compound binding.
  • Biophysical binding assessment: SPR, ITC, MST, TSA/CETSA to quantify binding affinity and thermal stabilization.
  • Phenotypic screening: Cell-based assays to identify activity signatures; follow-up deconvolution to determine MoA.
  • Chemoproteomics (if applicable): ABPP or pull-downs when derivatizable handles are available.

Assay development considerations (general):

  • Solubility ceilings: Establish maximum soluble concentration in your assay matrix at the intended DMSO percentage.
  • Aggregation/artifacts: Use detergent controls and orthogonal readouts to identify PAINS-like behavior (general literature guidance).
  • Redox/photoreactivity: If UV/visible excitation is used, monitor for inner-filter effects and photosensitivity.

Synthetic chemistry applications: Not typically applicable for an unknown structure. Once the structure is confirmed, classical functional group transformations and analogue synthesis may be planned to support SAR, but this cannot be detailed for AS70 without structural data.

Reaction Conditions

No reaction conditions can be specified for AS70 because the structure and functional groups are not disclosed.

General literature guidance for discovery chemistry once structure is available (not item-specific):

  • Diversification: Employ cross-couplings (Suzuki–Miyaura, Buchwald–Hartwig), amide couplings (EDC/HATU/DIC), and heterocycle formations to explore SAR.
  • Parallel synthesis: Use microwaves or high-throughput experimentation to optimize small arrays; typical temperatures 25–120 C, 0.5–16 h depending on transformation (literature ranges).
  • Purification/analysis: Reverse-phase prep HPLC or automated normal-phase flash; analytical UPLC with MS/UV for purity tracking.

Expected yields, catalysts, and solvent systems for AS70: Not specified for this item; refer to CoA/Spec Sheet.

Safety & Handling

Item-specific hazard data were not provided. Always consult the SDS for authoritative safety information.

Item-specific (from Product Data):

  • GHS classification: Not specified for this item; refer to SDS.
  • Signal word/H-statements/Pictograms: Not specified for this item; refer to SDS.
  • Storage conditions: Room temperature (as provided). Note: Maintain in a tightly closed container, away from strong oxidizers/reductants and moisture unless otherwise stated on the CoA/SDS.

General laboratory precautions for small-molecule screening compounds (not item-specific):

  • PPE: Lab coat, safety glasses, and suitable gloves (e.g., nitrile). Avoid inhalation of dusts/aerosols and skin contact.
  • Engineering controls: Handle powders in a ventilated hood; consider a balance enclosure for microgram weighing.
  • First aid (overview; defer to SDS): Inhalation—move to fresh air; Skin—wash with soap/water; Eyes—rinse cautiously with water; Ingestion—rinse mouth and seek medical advice.
  • Chemical hygiene: Prevent cross-contamination of screening libraries by using clean tips/plates; record freeze–thaw cycles for DMSO stocks.
  • Waste: Dispose according to local regulations; segregate halogenated vs non-halogenated organic waste. Decontaminate benches/equipment after handling.

Special risks (general):

  • Unknown toxicological profile: Treat as potentially harmful; minimize exposure.
  • DMSO carrier: Can enhance dermal absorption; avoid skin contact with solutions.
  • Dust generation: Minimize; use anti-static tools and weigh boats to prevent material loss and exposure.
Solvent Selection

Item-specific solvent data are not provided. The guidance below reflects general best practices for small-molecule screening compounds and should be validated experimentally for AS70.

  • Primary stock solvent (general): DMSO is the de facto solvent for discovery libraries due to broad solvency and biological compatibility at low v/v%.
  • Co-solvents for method development (general): Acetonitrile, methanol, ethanol for LC; isopropanol for intermediate polarity; DMF or NMP for challenging solids (ensure assay compatibility).
  • Aqueous compatibility (general): Use assay buffers that tolerate 0.1–1% DMSO; include non-ionic surfactants (e.g., 0.01–0.05% Tween-20) to mitigate aggregation, if appropriate.

Comparison (general; not item-specific):

  • DMSO: Broad solvency, excellent plate stability; can affect membrane permeability and enzyme kinetics at >1–2%.
  • DMF/NMP: Strong solvency; higher toxicity; use sparingly and verify assay tolerance.
  • Acetonitrile/Methanol: Useful for analytical prep and LC; volatile and assay-limiting for live-cell systems.

Practical tips (general):

  • Prepare a concentrated master stock (e.g., 10–50 mM in DMSO), then serially dilute into buffer immediately before use to minimize precipitation.
  • Confirm clarity by visual inspection and/or nephelometry at working concentrations.
  • Filter analytical samples (0.2 µm PTFE) before HPLC/UPLC to protect columns.

Item-specific solubility, logP, and UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.

Storage & Reconstitution

Item-specific (from Product Data):

  • Storage conditions: Room temperature.
  • Shipped in: Not specified for this item; refer to CoA/Spec Sheet.
  • Appearance/physical form: Not specified for this item; refer to CoA/Spec Sheet.

General guidance (not item-specific; validate against CoA/SDS):

  • If supplied as a solid: Store tightly closed in a dry environment, protected from light. For working stocks, dissolve in anhydrous DMSO to prepare a concentrated master solution (e.g., 10–50 mM), aliquot into inert vials/plates, and minimize freeze–thaw cycles.
  • If supplied as a solution: Keep container tightly sealed; avoid moisture ingress and prolonged exposure to elevated temperatures or light.
  • Reconstitution tips: Warm gently to room temperature, vortex/sonicate briefly to aid dissolution. Filter analytical samples (0.2 µm PTFE) if required.
  • Stability tracking: Record preparation date, solvent, concentration, and number of freeze–thaw events. Periodically re-check purity by LC–MS/UPLC.

Any stabilizers, water/peroxide limits, or UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.

Research use note: For research use only.

Structure & Identity

Item-specific identifiers provided for this SKU are limited. Where unavailable, consult the CoA/Spec Sheet for definitive values.

  • SKU: A607761 (AS70)
  • CAS: Not specified for this item; refer to CoA/Spec Sheet.
  • PubChem CID: 135443367 (as provided)
  • InChIKey: 35274 (as provided; note this is atypically short for a standard InChIKey)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance, not item-specific):

  • Without a disclosed structure (no SMILES/InChI, formula, or MW), functional groups, ring systems, and stereochemical elements cannot be enumerated for this item.
  • For Moligand-grade screening compounds, structures typically encompass drug-like chemical space (heteroaromatics, amide/urea linkages, sp2–sp3 balanced frameworks), but this is general chemical knowledge and not specific to AS70.

How to confirm identity in your lab (general best practices):

  • Orthogonal methods such as HRMS (ESI±), 1H/13C NMR, and HPLC/UPLC retention profiling against the vendor CoA chromatogram.
  • If the item is shipped as a defined salt/solvate, verify counterion/solvent content by 1H NMR integration and/or ion chromatography/Karl Fischer (literature/good practice).
Synthetic Utility

Without a disclosed structure, functional group content and reactivity of AS70 cannot be described. Therefore, item-specific synthetic applications are not provided.

General guidance for leveraging a screening compound in synthesis (not item-specific):

  • SAR expansion: Once the structure is known, identify modular vectors (e.g., aryl substituents, amide N-alkyl groups) for analogue synthesis to probe potency and physicochemical space.
  • Handle identification: If future target engagement studies are planned, design photoaffinity or clickable analogues (diazirine/alkyne) while preserving the core pharmacophore.
  • Solid-form/chemistry readiness: Characterize polymorph/solvate state and develop robust synthetic routes for scale-up should the compound become a lead.
  • IP strategy: Map novelty around the chemotype and substitution patterns; consider Markush coverage for key scaffolds.

Item-specific named reactions, reactivity notes, or derivatization handles: Not specified for this item; refer to CoA/Spec Sheet.

Target Specificity

Item-specific target, pathway, or selectivity data are not provided for AS70.

  • Antigen/epitope/clone/isotype: Not applicable; this product is a small molecule, not an antibody or protein reagent.
  • Known on-target/off-target profiles, IC50/Ki, or selectivity panels: Not specified for this item; refer to CoA/Spec Sheet.

General guidance (not item-specific):

  • Establish specificity via counterscreens against related targets, broad safety panels (e.g., kinome, GPCR, ion channels), and orthogonal biophysical confirmation.

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Moligand™ grade guide →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.